While the majority of ocular oncologists in the United States have adopted DecisionDx-UM as standard of care in the management of uveal melanoma, some centers may still be unfamiliar with the test.
If you would like to locate a doctor in your area who routinely performs DecisionDx-UM prognostic testing, please contact Castle Biosciences directly at: 866-788-9007.
